• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,058.45(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Valiant Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017
99.59 2 (1.53%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    97.90

  • Today’s High

    102.90

  • Open

    102.13

  • Perv Close

    98.09

  • 52W Low

    75.20

  • 52W High

    168.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    432.72

  • Div & Yield %

    0.00

  • Book Value(₹)

    52.91

  • Debt-Equity Ratio

    1.53

  • AGM Date

    29-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.41

  • Mar.Cap (₹Cr.)

    432.72

  • RONW (%)

    -1.71

  • ROCE (%)

    -1.63

Score Board

  • Equity (₹ in Cr.)

    43.45

  • BV (₹)

    52.90

  • Sales( ₹ in Cr.)

    182.05

  • NP (in Cr.)

    -2.86

  • NP Var(%)

    -110.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -0.70

  • Traded Value (₹ in Lakhs)

    446.80

  • 52 Week High

    168.00

  • 52 Week Low

    75.20

  • Price BSE

    103.0

  • Price NSE

    100.00

  • Market Capital( in Cr.)

    446.80

  • P/C Ratio

    -490.60

  • P/E Ratio

    -156.50

  • Price Vs.BV

    -0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 182.05 333.91 291.52 182.37 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 182.05 333.91 291.52 182.37 - -
Other Income 9.68 4.86 1.95 1.41 - -
Stock Adjustments 1.14 0.24 1.97 0.13 - -
Total Income 192.87 339.01 295.44 183.91 - -
EXPENDITURE :            
Raw Materials 168.66 276.76 236.19 120.53 - -
Power and Fuel Cost 8.33 7.37 4.38 3.17 - -
Employee Cost 4.31 4.61 3.06 2.71 - -
Other Manufacturing Expenses 6.07 4.86 3.70 3.55 - -
Selling and Administration Expenses 2.76 4.09 2.76 2.25 - -
Miscellaneous Expenses 1.46 1.37 1.09 0.29 - -
Employee Benefit Expenses 4.31 4.61 3.06 2.71 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 191.59 299.06 251.18 132.50 - -
Operating Profit 1.28 39.95 44.26 51.41 - -
Interest 0.08 0.25 0.07 1.78 - -
Gross Profit 1.20 39.70 44.19 49.63 - -
Depreciation 1.95 1.56 2.49 2.61 - -
Profit Before Tax -0.75 38.14 41.70 47.02 - -
Current Tax -0.98 8.80 14.47 16.46 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax -0.11 0.34 -0.26 -0.03 - -
Reported Net Profit 0.34 29.00 27.50 30.59 - -
Extraordinary Items 3.20 0.00 0.03 0.00 - -
Adjusted Net Profit -2.86 29.00 27.47 30.59 - -
Adjustment below Net Profit 0.18 0.03 -48.92 19.37 - -
P & L Balance brought forward 51.59 22.56 78.08 28.12 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 34.10 0.00 - -
P & L Balance carried down 52.11 51.59 22.56 78.08 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 0.08 8.91 16.89 29.14 - -
Earnings Per Share(Adj)-Unit Curr 0.08 - - - - -
Book Value 54.52 30.86 43.89 84.36 - -
Book Value(Adj)-Unit Curr 54.52 - - - - -

Shareholding Pattern

  • Promoter Group

    74.94%

  • Public Share Holding

    25.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,211,000 28.10 12,211,000 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 20,350,000 46.84 20,350,000 1
Sub Total 32,561,000 74.94 32,561,000 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 278,686 0.64 278,686 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 278,686 0.64 278,686 3
2] Non Institution
Bodies Corporate 2,962,541 6.82 2,962,541 66
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 70,639 0.16 70,639 91
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 472,612 1.09 472,612 530
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,584,251 5.95 2,584,251 34
Individuals holding nominal share capital up to Rs. 1 lakh 4,491,531 10.34 4,491,531 14,296
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,610,314 24.42 10,610,314 15,025
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 43,450,000 100.00 43,450,000 15,036

Company Background

Valiant Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Valiant Laboratories Ltd
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017

  • Incorporation Year

    2021

  • Registered Office

    104 Udyog Kshetra Mulund
    Goregaon Link Rd Mulund West, Mumbai,
    Maharashtra-400080

  • Telephone

    +91 22 49712001

  • FAX

  • Chairman

  • Managing Director

    Santosh S. Vora

  • Company Secretary

    Saloni Mehta

  • Auditor

    Raman S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Valiant Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Valiant Laborato 102.83 191.73 182.05 -67.65 -1.68
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92